Antiviral Drug Resistance Market to 2027 - Global Analysis and Forecasts By Product (Kits & Reagents and Instruments), Disease Indication (Human Immunodeficiency Virus [HIV], Hepatitis and Cytomegalovirus [CMV]), Technology (Immunodiagnostics, Polymerase Chain Reaction [PCR], Next Generation Sequencing [NGS], and Other Technologies), End User (Hospitals & Clinics, Pathology or Diagnostic Laboratories and Research Institutes), and Geography

The global antiviral drug resistance market is expected to reach US$ 4,573.24 Mn in 2027 from US$ 2,572.26 Mn in 2018. The Antiviral drug resistance market is estimated to grow with a CAGR of 6.8% from 2019-2027.
The market is driven by factors such as, rise in the incidences of hepatitis diseases and increasing prevalence of HIV/AIDS. However, the availability of alternative approaches may limit the growth of the market to a certain extent.
Antiviral drug resistance refers to decreased susceptibility towards a drug which occurs due to changes in viral genotypes. During instances of antiviral resistance, the drugs have either lost their effectiveness or have been diminished against the virus to be targeted. Antiviral drug resistance is a rising concern among the immune-compromised patients.
In spite of stringent quality control measures and advanced tools, a limited number of antiviral drugs are getting approved for human use. The mechanism of action of the antiviral drugs can differ, strengthening the immune response to the viral infection and ranging from targeting viral proteins to cellular proteins. Apart from antiviral drugs, some alternative approaches are used for the treatment of viral diseases. These approaches include antisense oligonucleotides, aptamers, immunomodulators, vaccines, and ribozymes. The antisense nucleotide method comprises targeting specific nucleotides rather than proteins. Besides, oligonucleic acid or peptide molecules that bind to a particular target molecule is known as Aptamer. The peptide aptamers are used to treat viral infections. The peptide aptamers are designed to restrict other protein interactions inside the cells.
Global antiviral drug resistance were segmented by product, disease indication, technology, and end user. The product segment was categorized as kits & reagents and instruments. On the basis of the disease indication, the market is segmented as Human Immunodeficiency Virus [HIV], Hepatitis and Cytomegalovirus [CMV]. Similarly, based on technology, the market is fragmented as, immunodiagnostics, polymerase chain reaction [PCR], next generation sequencing [NGS], and other technologies. Based on end user, the antiviral drug resistance market is categorized as, hospitals & clinics, pathology or diagnostic laboratories and research institutes.
Some of the major primary and secondary sources included in the report include, National Cancer Institute, National AIDS Research Institute, International Diabetes Federation, Centers for Disease Control and Prevention, and Food and Drug Administration, among others.

TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Antiviral Drug Resistance Market – By Product
1.3.2 Global Antiviral Drug Resistance Market – By Disease Indication
1.3.3 Global Antiviral Drug Resistance Market – By Technology
1.3.4 Global Antiviral Drug Resistance Market – By End User
1.3.5 Global Antiviral Drug Resistance Market – By Geography
2. Global Antiviral Drug Resistance Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Antiviral Drug Resistance Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert Opinion
4.4 Cost of Test, By Test Type
4.5 Test Volume, By Region
5. Global Antiviral Drug Resistance Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rise in the Incidences of Hepatitis Diseases
5.1.2 Increasing Prevalence of HIV/AIDS
5.2 Key Market Restraints
5.2.1 Alternative Approaches
5.3 Key Market Opportunities
5.3.1 Increasing Healthcare Expenditures in Emerging Markets
5.4 Future Trends
5.4.1 Demand For Higher Quality Products
5.5 Impact Analysis
6. Antiviral Drug Resistance Market – Global Analysis
6.1 Global Antiviral Drug Resistance Market Revenue Forecasts And Analysis
6.2 Global Antiviral Drug Resistance Market, By Geography - Forecasts And Analysis
6.3 Positioning of Key Players
7. Global Antiviral Drug Resistance Market Analysis– by Product
7.1 Overview
7.2 Global Antiviral Drug Resistance Market Share by Product 2018 & 2027 (%)
7.3 Kits and Reagents
7.3.1 Overview
7.3.2 Kits and Reagents Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market Revenue and Forecast to 2027 (US$ Mn)
8. Global Antiviral Drug Resistance Market Analysis– by Disease Indication
8.1 Overview
8.2 Global Antiviral Drug Resistance Market Share by Disease Indication 2018 & 2027 (%)
8.3 HIV
8.3.1 Overview
8.3.2 HIV Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Hepatitis
8.4.1 Overview
8.4.2 Hepatitis Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Cytomegalovirus (CMV)
8.5.1 Overview
8.5.2 Cytomegalovirus (CMV) Market Revenue and Forecast to 2027 (US$ Mn)
9. Global Antiviral Drug Resistance Market Analysis– by Technology
9.1 Overview
9.2 Global Antiviral Drug Resistance Market Share by Technology 2018 & 2027 (%)
9.3 Immunodiagnostics
9.3.1 Overview
9.3.2 Immunodiagnostics Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Polymerase Chain Reaction (PCR)
9.4.1 Overview
9.4.2 Polymerase Chain Reaction (PCR) Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Next Generation Sequencing (NGS)
9.5.1 Overview
9.5.2 Next Generation Sequencing (NGS) Market Revenue and Forecast to 2027 (US$ Mn)
9.6 Other Technologies
9.6.1 Overview
9.6.2 Other Technologies Market Revenue and Forecast to 2027 (US$ Mn)
10. Global Antiviral Drug Resistance Market Analysis– by End User
10.1 Overview
10.2 Global Antiviral Drug Resistance Market Share by End User 2018 & 2027 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals And Clinics Market Revenue and Forecast to 2027 (US$ Mn)
10.4 Pathology and Diagnostic Laboratories
10.4.1 Overview
10.4.2 Pathology and Diagnostic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
10.4.3 List of Laboratories, By Region
10.5 Research Institutes
10.5.1 Overview
10.5.2 Research Institutes Market Revenue and Forecast to 2027 (US$ Mn)
11. Antiviral Drug Resistance Market Revenue and Forecasts to 2027 – Geographical Analysis
11.1 North America Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.1.1 North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.2 North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.3 North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.1.4 North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.1.5 North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.6 North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.1.7 US Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.1 US Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.2 US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.7.3 US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.1.7.4 US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.1.7.5 US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.8 Canada Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.1 Canada Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.2 Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.8.3 Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.1.8.4 Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.1.8.5 Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.9 Mexico Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.1 Mexico Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.2 Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.9.3 Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.1.9.4 Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.1.9.5 Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2 Europe Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.2.1 Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.2 Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.3 Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.4 Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.5 Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.6 Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.2.7 UK Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.1 UK Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.2 UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.7.3 UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.7.4 UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.7.5 UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.8 Germany Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.1 Germany Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.2 Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.8.3 Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.8.4 Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.8.5 Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.9 France Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.1 France Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.2 France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.9.3 France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.9.4 France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.9.5 France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.10 Italy Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.1 Italy Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.2 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.10.3 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.10.4 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.10.5 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.11 Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.1 Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.2 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.11.3 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.11.4 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.11.5 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3 Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027
11.3.1 Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.2 Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.3 Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.4 Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.5 Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.6 Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.3.7 Japan Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.7.1 Japan Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.7.2 Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.7.3 Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.7.4 Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.7.5 Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.8 China Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8.1 China Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8.2 China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.8.3 China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.8.4 China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.8.5 China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.9 India Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.9.1 India Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.9.2 India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.9.3 India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.9.4 India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.9.5 India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.10 South Korea Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10.1 South Korea Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10.2 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.10.3 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.10.4 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.10.5 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.11 Australia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.11.1 Australia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.11.2 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.11.3 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.3.11.4 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.3.11.5 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.4.1 Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.2 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.3 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.4.4 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4.5 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.6 Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.4.7 UAE Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.1 UAE Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.2 UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.7.3 UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.4.7.4 UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4.7.5 UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.8 Saudi Arabia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.1 Saudi Arabia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.2 Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.8.3 Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.4.8.4 Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4.8.5 Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.9 South Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.1 South Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.2 South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.9.3 South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.4.9.4 South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4.9.5 South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5 South And Central America Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.5.1 South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.2 South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.5.3 South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.5.4 South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.5.5 South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5.6 South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
11.5.7 Argentina Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.7.1 Argentina Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.7.2 Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.5.7.3 Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.5.7.4 Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.5.7.5 Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5.8 Brazil Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8.1 Brazil Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8.2 Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.5.8.3 Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.5.8.4 Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.5.8.5 Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
12. Antiviral Drug Resistance Market– Industry Landscape
12.1 Overview
13. Antiviral Drug Resistance Market–Key Company Profiles
13.1 AccuBioTech Co., Ltd.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 ACON Laboratories, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Siemens AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 bioMérieux SA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Information
13.4.4 Product Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio-Rad Laboratories, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Information
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Danaher
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Overview
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Abbott
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BD
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 F. Hoffmann-La Roche Ltd.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Trinity Biotech
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES
Table 1. North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 2. North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 3. North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 4. North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 5. US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 6. US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 7. US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 8. US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 9. Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 10. Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 11. Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 12. Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 13. Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 14. Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 15. Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 16. Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 17. Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 18. Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 19. Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 20. Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 21. UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 22. UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 23. UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 24. UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 25. Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 26. Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 27. Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 28. Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 29. France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 30. France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 31. France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 32. France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 33. Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 34. Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 35. Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 36. Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 37. Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 38. Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 39. Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 40. Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 41. Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 42. Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 43. Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 44. Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 45. Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 46. Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 47. Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 48. Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 49. China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 50. China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 51. China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 52. China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 53. India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 54. India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 55. India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 56. India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 57. South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 58. South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 59. South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 60. South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 61. Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 62. Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 63. Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 64. Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 65. Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 66. Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 67. Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 68. Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 69. UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 70. UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 71. UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 72. UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 73. Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 74. Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 75. Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 76. Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 77. South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 78. South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 79. South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 80. South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 81. South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 82. South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 83. South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 84. South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 85. Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 86. Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 87. Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 88. Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 89. Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 90. Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 91. Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 92. Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 93. Glossary of Terms, Antiviral Drug Resistance Market

LIST OF FIGURES
Figure 1. Antiviral Drug Resistance Market Segmentation
Figure 2. Antiviral Drug Resistance Segmentation, by Region
Figure 3. Asia Pacific Antiviral Drug Resistance Market, Revenue (US$ Mn), 2018 & 2027
Figure 4. Global Antiviral Drug Resistance Market By Product, Market Share (%), 2018
Figure 5. Global Antiviral Drug Resistance Market By Disease Indication, Market Share (%), 2018
Figure 6. Global Antiviral Drug Resistance Market By Technology, Market Share (%), 2018
Figure 7. Global Antiviral Drug Resistance Market By End User, Market Share (%), 2018
Figure 8. North America : PEST Analysis
Figure 9. Europe: PEST Analysis
Figure 10. Asia - Pacific: PEST Analysis
Figure 11. Middle East & Africa: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Antiviral Drug Resistance Market Impact Analysis of Driver and Restraints
Figure 14. Global Antiviral Drug Resistance Market – Revenue Forecasts and Analysis – 2018- 2027
Figure 15. Global Antiviral Drug Resistance Market – by Geography Forecasts and Analysis – 2018- 2027
Figure 16. Prominent Players in the Antiviral Drug Resistance Market
Figure 17. Global Antiviral Drug Resistance Market Share by Product 2018 & 2027 (%)
Figure 18. Kits and Reagents Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. Instruments Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 20. Global Antiviral Drug Resistance Market Share by Disease Indication 2018 & 2027 (%)
Figure 21. HIV Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 22. Hepatitis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 23. Cytomegalovirus (CMV) Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 24. Global Antiviral Drug Resistance Market Share by Technology 2018 & 2027 (%)
Figure 25. Immunodiagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 26. Polymerase Chain Reaction (PCR) Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 27. Next Generation Sequencing (NGS) Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. Other Technologies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 29. Global Antiviral Drug Resistance Market Share by End User 2018 & 2027 (%)
Figure 30. Hospitals And Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 31. Pathology And Diagnostic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 32. RESEARCH INSTITUTES Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 33. North America Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 34. North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 36. US Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Canada Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. Mexico Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 39. Europe Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 40. Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 42. UK Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Germany Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. France Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 45. Italy Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 46. Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 47. Asia Pacific Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 48. Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 50. Japan Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. China Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 52. India Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 53. South Korea Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 54. Australia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 55. Middle East & Africa Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 56. Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 58. UAE Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 59. Saudi Arabia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 60. South Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 61. South and Central America Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 62. South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 63. South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 64. Argentina Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 65. Brazil Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)